According to a research report published by Spherical Insights and Consulting, The Global Respiratory Antiviral Treatment Market Size was worth around USD 2.45 Billion in 2024 and is Predicted to Grow to around USD 5.56 Billion by 2035 with a compound annual growth rate (CAGR) of 7.73% from 2025 and 2035.The global industry of respiratory antiviral treatment refers to the development, manufacturing, and selling of drugs used for treating viral infections of the respiratory tract.